StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
10
Publishing Date
2023 - 12 - 12
15
2023 - 12 - 11
18
2023 - 10 - 24
17
2023 - 10 - 23
16
2023 - 09 - 26
16
2023 - 09 - 11
16
2023 - 06 - 05
21
2023 - 05 - 25
22
2023 - 02 - 13
17
2022 - 12 - 08
19
2022 - 06 - 06
20
2022 - 05 - 26
15
2022 - 05 - 23
15
2022 - 03 - 01
17
2022 - 02 - 28
15
2022 - 01 - 18
17
2022 - 01 - 04
15
2021 - 12 - 16
16
2021 - 12 - 14
16
2021 - 12 - 13
29
2021 - 12 - 09
22
2021 - 12 - 06
24
2021 - 11 - 30
15
2021 - 11 - 16
17
2021 - 11 - 15
18
2021 - 11 - 09
16
2021 - 11 - 08
19
2021 - 11 - 03
20
2021 - 10 - 28
17
2021 - 10 - 27
15
2021 - 10 - 25
18
2021 - 10 - 20
16
2021 - 10 - 18
16
2021 - 10 - 14
18
2021 - 10 - 13
19
2021 - 10 - 07
19
2021 - 09 - 13
26
2021 - 09 - 09
16
2021 - 09 - 08
20
2021 - 08 - 31
15
2021 - 07 - 27
17
2021 - 07 - 15
15
2021 - 07 - 07
15
2021 - 07 - 06
16
2021 - 06 - 28
22
2021 - 06 - 24
16
2021 - 06 - 23
23
2021 - 06 - 16
16
2021 - 06 - 07
21
2021 - 05 - 12
15
2021 - 04 - 15
14
2021 - 04 - 12
16
2021 - 03 - 18
16
2021 - 03 - 15
15
2021 - 03 - 09
15
2021 - 02 - 10
14
2021 - 01 - 11
14
2020 - 12 - 15
14
2020 - 12 - 10
16
2020 - 12 - 01
15
Sector
Finance
1
Health technology
5
Process industries
1
Producer manufacturing
3
Tags
5g
2
Acquired
2
Acquisition
9
Acquisition corp
2
Application
2
Approval
3
Biomidwest
3
Biotech-beach
7
Biotechnology
5
Cancer
8
Ce mark
3
Ceo
5
Conference
47
Contract
6
Covid
10
Covid-19
5
Device
3
Diagnostic
7
Diagnostics
5
Disease
5
Earnings
9
Energy
12
Europe
4
Ev
6
Events
8
Expansion
3
Eye
3
Fda
3
Financial results
69
Genetown
3
Genomic
4
Growth
12
Health
12
Iot
5
Leo
6
Market
3
Media
4
N/a
420
Offering
9
Order
6
Partnership
3
People
3
Pharm-country
15
Pharma
3
Presentation
9
Product-news
7
Rare
3
Renewable
3
Report
31
Research
13
Results
152
Sales
8
Solar
3
Technology
15
Test
8
Therapeutics
5
Therapy
7
Treatment
3
Trial
10
Vaccine
6
Entities
Air products and chemicals, inc.
1
Belden inc
1
First industrial realty trust, inc.
1
Gates industrial corporation plc
1
Genprex, inc.
1
Incyte corporation
1
Johnson & johnson
1
Novavax, inc.
1
Orion energy systems, inc.
1
Replimune group, inc.
1
Sanofi
1
Zynerba pharmaceuticals, inc.
1
Symbols
APD
1
BDC
1
FR
1
GNPX
1
GTES
1
INCY
1
JNJ
1
NVAX
1
OESX
1
REPL
1
SNY
1
ZYNE
1
Exchanges
Nasdaq
6
Nyse
5
Crawled Date
2021 - 05 - 06
1
2021 - 05 - 05
9
Crawled Time
01:00
1
12:00
1
12:15
1
14:00
1
17:00
2
19:00
1
21:00
2
22:00
1
Source
www.biospace.com
4
www.globenewswire.com
1
www.prnewswire.com
4
www.zynerba.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 05 - 05
tags :
Trial
save search
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
NVAX
|
$4.205
3.32%
3.21%
3.6M
|
Health Technology
|
-97.75%
|
O:
3.47%
H:
4.31%
C:
-8.13%
covid
phase 2
results
vaccine
phase 2b
trial
trial results
Industrial Wires and Cables: Sourcing and Procurement Report| Evolving Opportunities and New Market Possibilities| SpendEdge
Published:
2021-05-05
(Crawled : 22:00)
- prnewswire.com
BDC
|
$84.23
1.03%
0.0%
190K
|
Producer Manufacturing
|
72.9%
|
O:
1.85%
H:
3.16%
C:
3.16%
new market
trial
Zynerba Pharmaceuticals Announces Phase 3 RECONNECT Trial Design for Zygel™ in Fragile X Syndrome
Published:
2021-05-05
(Crawled : 21:00)
- zynerba.com
ZYNE
|
$1.3
3.08%
860K
|
Health Technology
|
-70.18%
|
O:
1.61%
H:
1.13%
C:
-9.48%
phase 3
trial
syndros
designation
zygel
First Industrial Realty Trust Declares Common Stock Dividends
Published:
2021-05-05
(Crawled : 21:00)
- prnewswire.com
FR
|
$46.47
1.46%
0.0%
1M
|
Finance
|
-5.22%
|
O:
0.23%
H:
1.8%
C:
1.05%
trial
Air Products' CEO to Speak at Goldman Sachs Industrials and Materials Conference (Virtual) on May 12
Published:
2021-05-05
(Crawled : 19:00)
- prnewswire.com
APD
|
$233.71
-0.28%
0.0%
1.2M
|
Process Industries
|
-19.9%
|
O:
0.28%
H:
0.83%
C:
0.08%
ceo
trial
conference
leo
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
GNPX
|
$2.32
7.26%
6.77%
30K
|
Health Technology
|
-41.3%
|
O:
0.54%
H:
3.11%
C:
-1.89%
lung cancer
cancer
trial
approval
Scandal Watch: Elizabeth Holmes Appears in Court, Opioid Distributors on Trial and More
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
JNJ
|
News
|
$149.56
0.3%
0.0%
9.1M
|
Health Technology
|
-11.12%
|
O:
-0.16%
H:
0.0%
C:
-0.26%
INCY
|
$51.62
-0.58%
-0.58%
2.5M
|
Health Technology
|
-35.92%
|
O:
0.9%
H:
1.68%
C:
-0.59%
opioid
trial
Gates Industrial to Participate in the 2021 Goldman Sachs Industrials & Materials Conference
Published:
2021-05-05
(Crawled : 14:00)
- prnewswire.com
GTES
|
$17.65
2.62%
0.0%
1.6M
|
Producer Manufacturing
|
-0.69%
|
O:
0.4%
H:
0.35%
C:
-0.81%
trial
conference
Replimune Provides a Regulatory Update for its Registration- Directed Clinical Trials Evaluating RP1 in Combination with Libtayo® (cemiplimab)
Published:
2021-05-05
(Crawled : 12:15)
- biospace.com/
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-8.22%
|
O:
0.1%
H:
0.59%
C:
0.22%
REPL
|
$6.41
-0.16%
-0.16%
1.2M
|
Health Technology
|
-80.26%
|
O:
2.18%
H:
12.36%
C:
6.47%
clinical trials
trial
LED Lighting & Controls Provider Orion Extends Customer Value Proposition via Strategic Investment in ndustrial, Provider of IoT Industrial Optimization Solutions
Published:
2021-05-05
(Crawled : 12:00)
- globenewswire.com
OESX
|
$0.866
1.88%
1.85%
11K
|
Producer Manufacturing
|
-85.22%
|
O:
0.87%
H:
3.1%
C:
0.43%
iot
trial
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.